These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20419620)
1. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin. Voss S; Lüdke A; Romberg S; Schänzer E; Flenker U; deMarees M; Achtzehn S; Mester J; Schänzer W Int J Sports Med; 2010 Jun; 31(6):367-71. PubMed ID: 20419620 [TBL] [Abstract][Full Text] [Related]
2. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158 [TBL] [Abstract][Full Text] [Related]
3. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057 [TBL] [Abstract][Full Text] [Related]
4. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE. Desharnais P; Naud JF; Ayotte C Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues. Dehnes Y; Lamon S; Lönnberg M J Pharm Biomed Anal; 2010 Dec; 53(4):1028-32. PubMed ID: 20656433 [TBL] [Abstract][Full Text] [Related]
6. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE. Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487 [TBL] [Abstract][Full Text] [Related]
7. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters. Dehnes Y; Hemmersbach P Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570 [TBL] [Abstract][Full Text] [Related]
8. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control. Reichel C Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292 [TBL] [Abstract][Full Text] [Related]
9. Testing for recombinant erythropoietin. Delanghe JR; Bollen M; Beullens M Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255 [TBL] [Abstract][Full Text] [Related]
10. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application. Okano M; Sato M; Kaneko E; Kageyama S Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825 [TBL] [Abstract][Full Text] [Related]
11. The interference of heparin on IEF-PAGE of erythropoietins. Reichel C; Benetka E; Geisendorfer T; Scheiblhofer V; Abzieher F Drug Test Anal; 2010; 2(11-12):568-75. PubMed ID: 21204288 [TBL] [Abstract][Full Text] [Related]
12. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration. Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252 [TBL] [Abstract][Full Text] [Related]
13. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections. Dehnes Y; Shalina A; Myrvold L Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107 [TBL] [Abstract][Full Text] [Related]
14. [Determination methods for erythropoietin receptor activator in human urine]. Xing YY; Zhang LS; Xu YX; Wu MT; Wang S Yao Xue Xue Bao; 2009 Jul; 44(7):820-3. PubMed ID: 19806926 [TBL] [Abstract][Full Text] [Related]
15. How to confirm C.E.R.A. doping in athletes' blood? Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry. Stübiger G; Marchetti M; Nagano M; Reichel C; Gmeiner G; Allmaier G Rapid Commun Mass Spectrom; 2005; 19(5):728-42. PubMed ID: 15700237 [TBL] [Abstract][Full Text] [Related]
17. Improved detection methods significantly increase the detection window for EPO microdoses. Martin L; Martin JA; Collot D; Hoang O; Audran M; Ericsson M; Marchand A Drug Test Anal; 2021 Jan; 13(1):101-112. PubMed ID: 32737925 [TBL] [Abstract][Full Text] [Related]
18. Effects of exercise on the isoelectric patterns of erythropoietin. Lamon S; Martin L; Robinson N; Saugy M; Ceaurriz Jd; Lasne F Clin J Sport Med; 2009 Jul; 19(4):311-5. PubMed ID: 19638826 [TBL] [Abstract][Full Text] [Related]
19. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates. Reihlen P; Völker-Schänzer E; Majer B; Schänzer W Drug Test Anal; 2012 Nov; 4(11):813-7. PubMed ID: 22566398 [TBL] [Abstract][Full Text] [Related]
20. GASepo-a software solution for quantitative analysis of digital images in Epo doping control. Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]